Minimal Residual Disease in MM: What is the current status?

Learning objectives

After attending this meeting you should be able to:
- Explain the current treatment approaches for patients with multiple myeloma
- Discuss sequencing considerations in the management of patients with multiple myeloma
- Describe the immunological basis of multiple myeloma and its importance in the development of new therapeutic approaches